AIM-HER2 delivers automated and reproducible digital HER2 scoring with explainable AI heatmap visualizations. Now available on the AISight™ Image Management System.1
Confidently score HER2
Accurate and reproducible HER2 scoring to assist pathologists, especially in reviewing borderline cases and HER2 low expression.
Streamline Workflows
Multi-scanner compatibility plus automated whole slide image analysis and control tissue identification — no manual ROI selection.
Interpret and Explain
Additive MIL based heatmaps2 highlight features that drive HER2 score prediction, enabling human pathologist explainability.
Specifications
- Intended Use: Research Use Only
- Indications: Breast Cancer
- Clones: Ventana 4B5 and Dako HercepTest™
- Scanners: Leica Aperio® AT2 and GT450; Hamamatsu NanoZoomer® s360
- Inputs: Breast cancer biopsy, resection, and/or excision sample from primary, recurrent, or metastatic tumor (excluding in situ tumor)
- Outputs: HER2 score (0, 1+, 2+, 3+); Area of invasive carcinoma; Additive multiple instance learning (aMIL) density heatmap
AIM-HER2 Breast Cancer may be compatible with additional scanner types. Please contact us for more information.
AIM-HER2 Scoring Heatmaps
Additive MIL based heatmaps2 highlight tissue patterns features that most contribute to AIM-HER2's score prediction. Pathologists are able to more confidently assess HER2 expression, especially in borderline cases with more slide-level heterogeneity as they can quickly and more easily focus on the most critical features and slide areas.
.jpg)